Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases

Ioana Agache, Isabella Annesi-Maesano, Andreas Bonertz, Francesco Branca, Andrew Cant, Zlatko Fras, Frank Ingenrieth, Leyla Namazova-Baranova, Mikaela Odemyr, Antonio Spanevello, Stefan Vieths, Arzu Yorgancioglu, Montserat Alvaro-Lozano, Domingo Barber Hernandez, Tomás Chivato, Stefano Del Giacco, Zuzana Diamant, Ibon Eguiluz-Gracia, Roy Gert van Wijk, Philippe GevaertAnke Graessel, Peter Hellings, Karin Hoffmann-Sommergruber, Marek Jutel, Susanne Lau, Antti Lauerma, Jose Maria Olaguibel, Liam O'Mahony, Cevdet Ozdemir, Oscar Palomares, Oliver Pfaar, Joaquin Sastre, Glennis Scadding, Carsten Schmidt-Weber, Peter Schmid-Grendelmeier, Mohamed Shamji, Isabel Skypala, Monica Spinola, Otto Spranger, Maria Torres, Andrea Vereda, Sergio Bonini

Research output: Contribution to journalArticlepeer-review

26 Citations (SciVal)

Abstract

The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients’ organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics.

Original languageEnglish
Pages (from-to)2064-2076
Number of pages13
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume74
Issue number11
Early online date2019
DOIs
Publication statusPublished - 2019 Nov

Subject classification (UKÄ)

  • Social Sciences Interdisciplinary
  • Health Care Service and Management, Health Policy and Services and Health Economy
  • Medical Ethics

Keywords

  • allergic diseases
  • asthma
  • big data
  • environmental health
  • exposome
  • implementation science
  • quality criteria
  • translational research

Fingerprint

Dive into the research topics of 'Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases'. Together they form a unique fingerprint.

Cite this